Eli Lilly Earnings and Revenue beat in Q2
Investing.com - Eli Lilly (NYSE:LLY) reported second quarter earnings that beat analysts' expectations on Tuesday and revenue that topped forecasts.
The firm reported earnings per share of $1.5 on revenue of $5.64B. Analysts polled by Investing.com forecast EPS of $1.45 on revenue of $5.59B. That compared to EPS of $1.5 on revenue of $6.36B in the same period a year earlier. The company had reported EPS of $1.33 on revenue of $5.09B in the previous quarter.
Eli Lilly follows other major Healthcare sector earnings this month
On July 16, J&J reported second quarter EPS of $2.58 on revenue of $20.56B, compared to forecasts of EPS of $2.46 on revenue of $20.29B.
Pfizer earnings beat analysts' expectations on Monday, with second quarter EPS of $0.8 on revenue of $13.26B. Investing.com analysts expected EPS of $0.75 on revenue of $13.41B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar
Related Articles
Sirius XM Earnings, Revenue Beat in Q2
